Evidence map›Paper›PMID 27095918›Full record

ArticleCentral-European journal of immunology2016

Angiomodulatory properties of some antibiotics and Tołpa Peat Preparation.

Dorota M Radomska-Leśniewska, Ewa Skopińska-Różewska, Jarosław Jóźwiak, Urszula Demkow, Barbara Joanna Bałan

Open access · goldAbstract read
In one paragraph

Article in Central-European journal of immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dorota M Radomska-LeśniewskaDepartment of Histology and Embryology, Biostructure Centre, Medical University of Warsaw, Warsaw, Poland.
Ewa Skopińska-RóżewskaDepartment of Pathomorphology, Biostructure Centre, Medical University of Warsaw, Warsaw, Poland; Military Institute of Hygiene and Epidemiology, Warsaw, Poland.
Jarosław JóźwiakDepartment of Histology and Embryology, Biostructure Centre, Medical University of Warsaw, Warsaw, Poland.
Urszula DemkowDepartment of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Warsaw, Poland.
Barbara Joanna BałanDepartment of Immunology, Biochemistry, and Nutrition, Medical University of Warsaw, Warsaw, Poland.
Medical University of Warsaw · PLWojskowy Instytut Higieny i Epidemiologii · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledDeterioration of the immune system due to antibiotic therapy can be restored by immunomodulator application. In this paper we estimate the effect of ampicillin, amikacin, doxycycline, rifampicin, rifamycine and immunomodulator Tołpa Peat Preparation (TPP) on neovascular reaction induced in murine skin by human mononuclear cells (MNC) injection. MNC originating from 15 healthy volunteers were injected intradermally to Balb/c mice. Antibiotics (3, 15, or 75 mg/kg of body weight) alone or with TPP (10 mg/kg of body weight) were administrated subcutaneously to mice on three consecutive days. The number of newly formed blood vessels was measured in dissection microscope 72 hours after cell injection.

resultsTPP stimulated angiogenic activity of MNC at the dose 5 and 10 mg/kg. Rifamycine exerted strong stimulatory action, ampicillin slightly stimulated immune response, while doxycycline and rifampicin downregulated it. Amikacin did not influence the results of angiogenesis tests. Studied antibiotics (15 mg/kg), except rifamycine, inhibit the angiostimulatory effect of the tested immunomodulator. TPP should be applied after antibiotic therapy to maintain its stimulatory effect and restore proper host immune function.

Indexed as

amikacinampicillinangiogenesisantibioticsdoxycyclineimmune systemrifampicinrifamycineTołpa Peat Preparation (TPP)

Identifiers

PMID27095918
PMCPMC4829815
OpenAlexW2353615185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.